{
 "as_of": "2026-11-06",
 "cmr": "se-cm-kg/XSTO/SE0020388577",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Cinclus Pharma Holding AB (Nasdaq Stockholm: SE0020388577) — research page\n\nAs of 2026-11-06 · se-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Cinclus Pharma Holding AB, listed on Nasdaq Stockholm under ticker SE0020388577. Its ISIN is SE0020388577 and its LEI is 549300TJBPSNZ3DO6B42. Security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 35 filings across 30 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 8 days, against a median of 9.5 days for Nasdaq Stockholm issuers. The record holds 7 days from the latest filing to the record date, against a Nasdaq Stockholm median of 7.0 days. The latest filing is dated 2026-10-30 and is of type Total number of voting rights and capital. The sector median is not on the record.\n\n## Auditor\n\nThe auditor of record and its location are not on the record. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as the index carries no lifecycle type for this register. The issuer is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable for this issuer. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 4 research houses: ABG Sundal Collier, Stifel, Carnegie Investment Bank AB and Redeye.\n\n## Open research\n\nNo openly published research notes are on the record for this issuer.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began is not on the record.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.se-cm-kg.ai/events/XSTO/SE0020388577 (the disclosure lines)\n- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)\n- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://cincluspharma.com/investors/the-share/analyst-coverage/ (coverage)\n- https://mcp.se-cm-kg.ai/record/XSTO/SE0020388577 (the record)\n",
 "market": "SE",
 "node": "se-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the SE vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "SE",
    "state": "not_on_record"
   },
   "changes": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "se-cm-kg/XSTO/SE0020388577",
  "coverage": {
   "count": 4,
   "houses": [
    {
     "analyst": "Georg Tigalonov-Bjerke",
     "house": "ABG Sundal Collier",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://cincluspharma.com/investors/the-share/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Oscar Haffen-Lamm",
     "house": "Stifel",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://cincluspharma.com/investors/the-share/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Arvid Necander",
     "house": "Carnegie Investment Bank AB",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://cincluspharma.com/investors/the-share/analyst-coverage/",
     "state": "sourced"
    },
    {
     "house": "Redeye",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://cincluspharma.com/investors/the-share/analyst-coverage/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://cincluspharma.com/investors/the-share/analyst-coverage/",
     "result": "read: 4 of 8 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 398,
     "median_cadence_gap_days": 9.5,
     "median_filings": 30,
     "median_latency_days": 7,
     "name": "Nasdaq Stockholm"
    },
    "sector": {
     "market": "SE",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "Annual Financial Report": 1,
    "Changes board/management/auditors": 1,
    "Decisions of general meeting": 2,
    "Financial Statement Release": 2,
    "Half Year financial report": 1,
    "Inside information": 2,
    "Interim report (Q1 and Q3)": 3,
    "Investor News": 16,
    "Notice to general meeting": 2,
    "Other information disclosed according to the rules of the Exchange": 4,
    "Total number of voting rights and capital": 1
   },
   "cadence_median_gap_days": 8,
   "filing_days": 30,
   "filings": 35,
   "latency_days": 7,
   "latest": [
    {
     "category": "Total number of voting rights and capital",
     "date": "2026-10-30",
     "source": "https://view.news.eu.nasdaq.com/view?id=bf0edff5a681bf04a024e766f9132ddfd&lang=en&src=listed",
     "title": "Number of shares and votes in Cinclus Pharma",
     "type": "Total number of voting rights and capital"
    },
    {
     "category": "Investor News",
     "date": "2026-10-29",
     "source": "https://view.news.eu.nasdaq.com/view?id=b4ef1eb346937e9299d35aa2a18a130f1&lang=en&src=listed",
     "title": "Invitation to presentation of Cinclus Pharma's third quarter report 2026",
     "type": "Investor News"
    },
    {
     "category": "Other information disclosed according to the rules of the Exchange",
     "date": "2026-10-27",
     "source": "https://view.news.eu.nasdaq.com/view?id=ba15679631974bbd5afc1b01d02159825&lang=en&src=listed",
     "title": "CINCLUS PHARMA'S NOMINATION COMMITTEE FOR THE 2027 ANNUAL GENERAL MEETING APPOINTED",
     "type": "Other information disclosed according to the rules of the Exchange"
    },
    {
     "category": "Investor News",
     "date": "2026-10-20",
     "source": "https://view.news.eu.nasdaq.com/view?id=bb88afdcaba3a70fbc3b450c99628847b&lang=en&src=listed",
     "title": "Cinclus Pharma to participate in upcoming investor conferences",
     "type": "Investor News"
    },
    {
     "category": "Other information disclosed according to the rules of the Exchange",
     "date": "2026-10-07",
     "source": "https://view.news.eu.nasdaq.com/view?id=ba082f7287e5568662eaf754f84ba57dd&lang=en&src=listed",
     "title": "Issuance and repurchase of class C shares for incentive program",
     "type": "Other information disclosed according to the rules of the Exchange"
    }
   ],
   "latest_filing_date": "2026-10-30",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.se-cm-kg.ai/events/XSTO/SE0020388577",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "Nasdaq Stockholm"
   },
   "isin": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0020388577"
   },
   "jurisdiction": {
    "market": "SE",
    "state": "not_on_record"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN SE0020388577)",
    "state": "sourced",
    "value": "549300TJBPSNZ3DO6B42"
   },
   "name": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "Cinclus Pharma Holding AB"
   },
   "sector": {
    "market": "SE",
    "state": "not_on_record"
   },
   "security_type": {
    "market": "SE",
    "state": "not_on_record"
   },
   "segment": {
    "market": "SE",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0020388577"
   },
   "website": {
    "market": "SE",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "SE",
  "node": "se-cm-kg",
  "numbers_hash": "sha256:cd9d69d902fdfc7802e46797fca656942ff47ee3c71a41599052f9b074a7cf0b",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://se.eu-cm-kg.ai/book/aio.json",
    "door": "https://se.eu-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/se/mifid-ii-product-governance/r1",
   "section": "se.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.se-cm-kg.ai/record/XSTO/SE0020388577",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:cd9d69d902fdfc7802e46797fca656942ff47ee3c71a41599052f9b074a7cf0b",
 "path": "/se/XSTO/SE0020388577",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Cinclus Pharma Holding AB, listed on Nasdaq Stockholm under ticker SE0020388577. Its ISIN is SE0020388577 and its LEI is 549300TJBPSNZ3DO6B42. Security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 35 filings across 30 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 8 days, against a median of 9.5 days for Nasdaq Stockholm issuers. The record holds 7 days from the latest filing to the record date, against a Nasdaq Stockholm median of 7.0 days. The latest filing is dated 2026-10-30 and is of type Total number of voting rights and capital. The sector median is not on the record.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record and its location are not on the record. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as the index carries no lifecycle type for this register. The issuer is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable for this issuer. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 4 research houses: ABG Sundal Collier, Stifel, Carnegie Investment Bank AB and Redeye.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes are on the record for this issuer.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://firds.esma.europa.eu/firds/"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.se-cm-kg.ai/events/XSTO/SE0020388577"
  },
  {
   "for": "the halt flag",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation"
  },
  {
   "for": "the orderability chapter",
   "source": "https://se.eu-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://cincluspharma.com/investors/the-share/analyst-coverage/"
  },
  {
   "for": "the record",
   "source": "https://mcp.se-cm-kg.ai/record/XSTO/SE0020388577"
  }
 ],
 "title": "Cinclus Pharma Holding AB (SE0020388577) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}